每日經濟新(xin)聞 2022-07-28 17:48:34
每經(jing)AI快(kuai)訊(xun),康龍(long)(long)(long)化成(cheng)(SZ 300759,收(shou)盤價:82.38元)7月28日晚(wan)間發布公告(gao)稱(cheng),截至本公告(gao)日,樓(lou)小(xiao)強累(lei)(lei)(lei)計(ji)(ji)質(zhi)(zhi)(zhi)押(ya)(ya)(ya)股(gu)(gu)(gu)(gu)(gu)數(shu)(shu)(shu)(shu)(shu)(shu)約(yue)(yue)為(wei)(wei)(wei)(wei)840萬(wan)股(gu)(gu)(gu)(gu)(gu),占(zhan)其所(suo)(suo)(suo)持(chi)(chi)股(gu)(gu)(gu)(gu)(gu)份(fen)比例(li)(li)為(wei)(wei)(wei)(wei)16.71%。龍(long)(long)(long)泰(tai)(tai)康累(lei)(lei)(lei)計(ji)(ji)質(zhi)(zhi)(zhi)押(ya)(ya)(ya)股(gu)(gu)(gu)(gu)(gu)數(shu)(shu)(shu)(shu)(shu)(shu)約(yue)(yue)為(wei)(wei)(wei)(wei)1302萬(wan)股(gu)(gu)(gu)(gu)(gu),占(zhan)其所(suo)(suo)(suo)持(chi)(chi)股(gu)(gu)(gu)(gu)(gu)份(fen)比例(li)(li)為(wei)(wei)(wei)(wei)40.36%。 Pharmaro n HoldingsLimited累(lei)(lei)(lei)計(ji)(ji)質(zhi)(zhi)(zhi)押(ya)(ya)(ya)股(gu)(gu)(gu)(gu)(gu)數(shu)(shu)(shu)(shu)(shu)(shu)為(wei)(wei)(wei)(wei)0股(gu)(gu)(gu)(gu)(gu),占(zhan)其所(suo)(suo)(suo)持(chi)(chi)股(gu)(gu)(gu)(gu)(gu)份(fen)比例(li)(li)為(wei)(wei)(wei)(wei)0%。鄭北累(lei)(lei)(lei)計(ji)(ji)質(zhi)(zhi)(zhi)押(ya)(ya)(ya)股(gu)(gu)(gu)(gu)(gu)數(shu)(shu)(shu)(shu)(shu)(shu)約(yue)(yue)為(wei)(wei)(wei)(wei)28萬(wan)股(gu)(gu)(gu)(gu)(gu),占(zhan)其所(suo)(suo)(suo)持(chi)(chi)股(gu)(gu)(gu)(gu)(gu)份(fen)比例(li)(li)為(wei)(wei)(wei)(wei)2.44%。北京多泰(tai)(tai)累(lei)(lei)(lei)計(ji)(ji)質(zhi)(zhi)(zhi)押(ya)(ya)(ya)股(gu)(gu)(gu)(gu)(gu)數(shu)(shu)(shu)(shu)(shu)(shu)為(wei)(wei)(wei)(wei)860萬(wan)股(gu)(gu)(gu)(gu)(gu),占(zhan)其所(suo)(suo)(suo)持(chi)(chi)股(gu)(gu)(gu)(gu)(gu)份(fen)比例(li)(li)為(wei)(wei)(wei)(wei)44.36%。廈(sha)(sha)(sha)門(men)(men)(men)龍(long)(long)(long)泰(tai)(tai)鼎(ding)盛企(qi)業(ye)管理(li)(li)合伙(huo)(huo)企(qi)業(ye)(有(you)限(xian)合伙(huo)(huo))累(lei)(lei)(lei)計(ji)(ji)質(zhi)(zhi)(zhi)押(ya)(ya)(ya)股(gu)(gu)(gu)(gu)(gu)數(shu)(shu)(shu)(shu)(shu)(shu)為(wei)(wei)(wei)(wei)0股(gu)(gu)(gu)(gu)(gu),占(zhan)其所(suo)(suo)(suo)持(chi)(chi)股(gu)(gu)(gu)(gu)(gu)份(fen)比例(li)(li)為(wei)(wei)(wei)(wei)0%。廈(sha)(sha)(sha)門(men)(men)(men)龍(long)(long)(long)泰(tai)(tai)匯盛企(qi)業(ye)管理(li)(li)合伙(huo)(huo)企(qi)業(ye)(有(you)限(xian)合伙(huo)(huo))累(lei)(lei)(lei)計(ji)(ji)質(zhi)(zhi)(zhi)押(ya)(ya)(ya)股(gu)(gu)(gu)(gu)(gu)數(shu)(shu)(shu)(shu)(shu)(shu)為(wei)(wei)(wei)(wei)0股(gu)(gu)(gu)(gu)(gu),占(zhan)其所(suo)(suo)(suo)持(chi)(chi)股(gu)(gu)(gu)(gu)(gu)份(fen)比例(li)(li)為(wei)(wei)(wei)(wei)0%。廈(sha)(sha)(sha)門(men)(men)(men)龍(long)(long)(long)泰(tai)(tai)匯信(xin)企(qi)業(ye)管理(li)(li)合伙(huo)(huo)企(qi)業(ye)(有(you)限(xian)合伙(huo)(huo))累(lei)(lei)(lei)計(ji)(ji)質(zhi)(zhi)(zhi)押(ya)(ya)(ya)股(gu)(gu)(gu)(gu)(gu)數(shu)(shu)(shu)(shu)(shu)(shu)為(wei)(wei)(wei)(wei)0股(gu)(gu)(gu)(gu)(gu),占(zhan)其所(suo)(suo)(suo)持(chi)(chi)股(gu)(gu)(gu)(gu)(gu)份(fen)比例(li)(li)為(wei)(wei)(wei)(wei)0%。廈(sha)(sha)(sha)門(men)(men)(men)龍(long)(long)(long)泰(tai)(tai)眾(zhong)(zhong)盛企(qi)業(ye)管理(li)(li)合伙(huo)(huo)企(qi)業(ye)(有(you)限(xian)合伙(huo)(huo))累(lei)(lei)(lei)計(ji)(ji)質(zhi)(zhi)(zhi)押(ya)(ya)(ya)股(gu)(gu)(gu)(gu)(gu)數(shu)(shu)(shu)(shu)(shu)(shu)為(wei)(wei)(wei)(wei)0股(gu)(gu)(gu)(gu)(gu),占(zhan)其所(suo)(suo)(suo)持(chi)(chi)股(gu)(gu)(gu)(gu)(gu)份(fen)比例(li)(li)為(wei)(wei)(wei)(wei)0%。廈(sha)(sha)(sha)門(men)(men)(men)龍(long)(long)(long)泰(tai)(tai)眾(zhong)(zhong)信(xin)企(qi)業(ye)管理(li)(li)合伙(huo)(huo)企(qi)業(ye)(有(you)限(xian)合伙(huo)(huo))累(lei)(lei)(lei)計(ji)(ji)質(zhi)(zhi)(zhi)押(ya)(ya)(ya)股(gu)(gu)(gu)(gu)(gu)數(shu)(shu)(shu)(shu)(shu)(shu)為(wei)(wei)(wei)(wei)0股(gu)(gu)(gu)(gu)(gu),占(zhan)其所(suo)(suo)(suo)持(chi)(chi)股(gu)(gu)(gu)(gu)(gu)份(fen)比例(li)(li)為(wei)(wei)(wei)(wei)0%。
2021年1至12月(yue)份(fen),康龍化(hua)成的(de)營業(ye)收入構(gou)成為:科學研究(jiu)和技術服(fu)務業(ye)占比99.67%。
康龍(long)化成的董事(shi)長是(shi)Boliang Lou,男,59歲,學歷背景為博士。
截至(zhi)發稿,康龍化(hua)成(cheng)市值為(wei)981億元(yuan)。
道達號(daoda1997)“個(ge)股趨(qu)勢”提(ti)醒:
1. 康龍化成近30日內北向資金持股量增加837.88萬股,占流通股比例增加0.89%;
2. 近30日內共有1批機構對康龍化成調研,合計調研的機構家數為20家。
更多個股(gu)趨勢信息,請搜索(suo)微信公(gong)眾號(hao)“道達號(hao)”,回復“查詢”,領取免費查詢權限(xian)!
每經頭條(nbdtoutiao)——
(記者 曾健輝)
免(mian)責聲明:本文(wen)內(nei)容與數(shu)據僅供參(can)考,不構成投資建(jian)議,使用前請核實。據此操作,風險(xian)自擔(dan)。
如需轉載請與《每日經濟新聞》報社聯系。
未經(jing)《每日(ri)經(jing)濟新聞》報社授權,嚴(yan)禁轉載或鏡像,違者必究。
讀者(zhe)熱線(xian):4008890008
特別提醒:如果我們使用了您的圖片,請作者與本站聯系索(suo)取稿(gao)酬。如您不希望作品出現在本站,可聯系(xi)我們要求撤下(xia)您的(de)作品。
歡迎關注(zhu)每日經(jing)濟新聞APP